Filed: 8/8/2025ACC: 0001395064-25-000124
📋 What this filing means
TAKEDA PHARMACEUTICAL CO LTD filed this quarterly 13F‑HR report disclosing 11 equity positions with a total reported market value of $19.55M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
11
Positions
$19.55M
Total AUM (reported)
19.34M
Total Shares
Allocation by class
COM$19.55M100.0%
Portfolio Concentration
Top 3$16.87M86.3%
4–10$2.66M13.6%
11–25$19.8K0.1%
Top 3 weight
86.3%
Top 10 weight
99.9%
Voting Authority Distribution
Total shares with voting rights: 19.34M
Sole
Full voting authority
19.34M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other11
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings11
Rows:
HilleVax, Inc.
DFNDShares6.72M
TypeSH
Market value$13.38M
68.43%
Sole
6.72M
Shared
0.00
None
0.00
Ovid Therapeutics, Inc.
DFNDShares7.53M
TypeSH
Market value$2.49M
12.71%
Sole
7.53M
Shared
0.00
None
0.00
Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)
DFNDShares1.48M
TypeSH
Market value$1.00M
5.13%
Sole
1.48M
Shared
0.00
None
0.00
American Well Corporation
DFNDShares77.73K
TypeSH
Market value$691.0K
3.53%
Sole
77.73K
Shared
0.00
None
0.00
Equillium, Inc.
DFNDShares1.82M
TypeSH
Market value$575.2K
2.94%
Sole
1.82M
Shared
0.00
None
0.00
Shattuck Labs, Inc.
DFNDShares515.62K
TypeSH
Market value$408.3K
2.09%
Sole
515.62K
Shared
0.00
None
0.00
Lyell Immunopharma, Inc.
DFNDShares41.16K
TypeSH
Market value$363.9K
1.86%
Sole
41.16K
Shared
0.00
None
0.00
Turnstone Biologics
DFNDShares895.82K
TypeSH
Market value$321.6K
1.64%
Sole
895.82K
Shared
0.00
None
0.00
Third Harmonic Bio, Inc.
DFNDShares36.84K
TypeSH
Market value$200.0K
1.02%
Sole
36.84K
Shared
0.00
None
0.00
Rani Therapeutics Holdings, Inc.
DFNDShares203.19K
TypeSH
Market value$104.4K
0.53%
Sole
203.19K
Shared
0.00
None
0.00
Standard Biotools, Inc.
DFNDShares16.52K
TypeSH
Market value$19.8K
0.10%
Sole
16.52K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
HilleVax, Inc.DFND | COM | 6.72M | SH | $13.38M 68.43% | 6.72M | 0.00 | 0.00 |
Ovid Therapeutics, Inc.DFND | COM | 7.53M | SH | $2.49M 12.71% | 7.53M | 0.00 | 0.00 |
Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)DFND | COM | 1.48M | SH | $1.00M 5.13% | 1.48M | 0.00 | 0.00 |
American Well CorporationDFND | COM | 77.73K | SH | $691.0K 3.53% | 77.73K | 0.00 | 0.00 |
Equillium, Inc.DFND | COM | 1.82M | SH | $575.2K 2.94% | 1.82M | 0.00 | 0.00 |
Shattuck Labs, Inc.DFND | COM | 515.62K | SH | $408.3K 2.09% | 515.62K | 0.00 | 0.00 |
Lyell Immunopharma, Inc.DFND | COM | 41.16K | SH | $363.9K 1.86% | 41.16K | 0.00 | 0.00 |
Turnstone BiologicsDFND | COM | 895.82K | SH | $321.6K 1.64% | 895.82K | 0.00 | 0.00 |
Third Harmonic Bio, Inc.DFND | COM | 36.84K | SH | $200.0K 1.02% | 36.84K | 0.00 | 0.00 |
Rani Therapeutics Holdings, Inc.DFND | COM | 203.19K | SH | $104.4K 0.53% | 203.19K | 0.00 | 0.00 |
Standard Biotools, Inc.DFND | COM | 16.52K | SH | $19.8K 0.10% | 16.52K | 0.00 | 0.00 |